Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
AstraZeneca
Dana-Farber Cancer Institute
Mayo Clinic
Hoffmann-La Roche
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Psyence Australia Pty Ltd
Neonc Technologies, Inc.
ViroMissile, Inc.
Bristol-Myers Squibb
Dana-Farber Cancer Institute
Kaiser Permanente
Children's Oncology Group
Pfizer
University of Florida
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
National Institutes of Health Clinical Center (CC)
Genentech, Inc.
Shanghai Henlius Biotech
OHSU Knight Cancer Institute
Wake Forest University Health Sciences
Sapience Therapeutics
MacroGenics
St. Jude Children's Research Hospital
MacroGenics
Adaptimmune
University of California, Davis
City of Hope Medical Center
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Second Life Therapeutics
ImmunityBio, Inc.
NRG Oncology
Innate Pharma
Novartis
Bayer
City of Hope Medical Center
OncoNano Medicine, Inc.
City of Hope Medical Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Incyte Corporation
Regeneron Pharmaceuticals
Memorial Sloan Kettering Cancer Center